Innospec Inc. (NASDAQ:IOSP) Shares Acquired by Vanguard Group Inc.

Vanguard Group Inc. increased its position in shares of Innospec Inc. (NASDAQ:IOSP) by 0.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,941,356 shares of the specialty chemicals company’s stock after purchasing an additional 11,502 shares during the quarter. Vanguard Group Inc. owned 11.83% of Innospec worth $300,607,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Belpointe Asset Management LLC lifted its stake in Innospec by 226.2% in the first quarter. Belpointe Asset Management LLC now owns 274 shares of the specialty chemicals company’s stock valued at $28,000 after buying an additional 190 shares during the last quarter. Captrust Financial Advisors lifted its stake in Innospec by 74.7% in the first quarter. Captrust Financial Advisors now owns 498 shares of the specialty chemicals company’s stock valued at $46,000 after buying an additional 213 shares during the last quarter. Point72 Middle East FZE bought a new stake in Innospec in the fourth quarter valued at $57,000. Point72 Hong Kong Ltd bought a new stake in Innospec in the first quarter valued at $53,000. Finally, Pinebridge Investments L.P. lifted its stake in Innospec by 102.6% in the second quarter. Pinebridge Investments L.P. now owns 778 shares of the specialty chemicals company’s stock valued at $78,000 after buying an additional 394 shares during the last quarter. 96.64% of the stock is currently owned by institutional investors.

Innospec Stock Performance

IOSP stock opened at $129.55 on Thursday. The stock has a market capitalization of $3.22 billion, a price-to-earnings ratio of 23.26 and a beta of 1.10. Innospec Inc. has a 1 year low of $91.74 and a 1 year high of $131.18. The stock’s fifty day moving average is $122.14 and its two-hundred day moving average is $112.82.

Innospec (NASDAQ:IOSP) last posted its earnings results on Tuesday, February 13th. The specialty chemicals company reported $1.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.59 by $0.25. The company had revenue of $494.70 million for the quarter, compared to analysts’ expectations of $479.47 million. Innospec had a return on equity of 13.69% and a net margin of 7.14%. The firm’s quarterly revenue was down 3.1% compared to the same quarter last year. During the same period last year, the business posted $1.20 earnings per share. As a group, analysts predict that Innospec Inc. will post 6.72 EPS for the current fiscal year.

Insider Activity

In other Innospec news, Director Leslie J. Parrette purchased 410 shares of the stock in a transaction dated Thursday, February 22nd. The shares were bought at an average cost of $123.96 per share, with a total value of $50,823.60. Following the completion of the acquisition, the director now owns 3,620 shares of the company’s stock, valued at $448,735.20. The purchase was disclosed in a filing with the SEC, which is available through this link. In other Innospec news, Director Leslie J. Parrette purchased 410 shares of the stock in a transaction dated Thursday, February 22nd. The shares were bought at an average cost of $123.96 per share, with a total value of $50,823.60. Following the completion of the acquisition, the director now owns 3,620 shares of the company’s stock, valued at $448,735.20. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, SVP David B. Jones sold 2,500 shares of the firm’s stock in a transaction on Friday, March 1st. The shares were sold at an average price of $125.79, for a total value of $314,475.00. Following the transaction, the senior vice president now directly owns 9,664 shares in the company, valued at $1,215,634.56. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 36,500 shares of company stock valued at $4,532,959. Company insiders own 1.35% of the company’s stock.

Innospec Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.